CLAUDIO GINEBRA: Open Payments
NPI 1821350786 · MEDFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 10 payments from 5 companies in 2025. Trend: 2023 $362 · 2024 $113 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $279 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Alpha Cognition USA, Inc. | 2 | $105 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $15 |
Products named: REXULTI, LOKELMA, Zunveyl, AUSTEDO XR, LINZESS.
Industry payments across NY — which companies pay providers there.
